Member Info for Spkr13

Fully agree SMT, the spread make me even more stubborn to see this one out. : ) GL

Open Offer to Qualifying Shareholders

In order to provide Shareholders who have not taken part in the Placing or the Subscription with an opportunity to participate in the Fundraising, the Company intends to make an Open Offer to Qualifying Shareholders on the terms and conditions to be set out in the Circular. The Open Offer provides Qualifying Shareholders with the opportunity to subscribe at the Issue Price for an aggregate of up to 13,946,397 Open Offer Shares to raise up to approximately £4.2 million (before fees and expenses) for the Company, on the basis of:

2 Open Offer Shares for every 17 Ordinary Shares held as at the Record Date.

The Open Offer is conditional on the Placing and the Subscription becoming or being declared unconditional in all respects and not being terminated before Admission. Accordingly, if the conditions to the Placing and the Subscription (including the passing of the Fundraising Resolutions) are not satisfied or waived (where capable of waiver), the Open Offer will not proceed.

Further details of the Open Offer and the terms and conditions on which it is being made, including the procedure for application and payment, will be contained in the Circular, which shall be posted to Shareholders and made available on the Company's website, www.shieldtherapeutics.com, on or around 1 March 2021. A further announcement will confirm the posting date and availability of the Circular on the Company's website.

Capitalised terms in this announcement shall, unless the context demands otherwise, bear the meanings given to such terms in the announcement of the Transaction made via RNS on 26 February 2021.

Very light trading today especially this PM. The spread was actually quite tight. Sells approx 330 buys 336p.
It's just a waiting game now.
''Patience rewards those who wait'' GLA

Yes the spread is a put off, but there does seem to be some momentum gathering. If you time it right you can sneak one a 5% spread out of them !!
Looking at the late trades I am hoping for another solid start to day with an open of 105p (without RNS)
I certainly feel more relaxed this week, the future looks bright. GLA

Manchester, UK - 22 February 2021: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that its partnership with Newcastle Premier Health Limited1 ("NPH"), a leading provider of independent medical services in Newcastle and the North East, will supply COVID-19 PCR testing services to Leeds Bradford Airport from the Company's laboratory in Manchester.

Yourgene and NPH are partnering with Leeds Bradford Airport2 ("LBA") to offer an onsite COVID-19 service for departing and arriving passengers, and for the local community. NPH has successfully implemented a similar testing service at Newcastle Airport and will now look to mirror that offering at LBA , using Yourgene's Clarigene® SARS-CoV-2 assay and its high throughput COVID-19 service laboratory in Manchester to test samples taken at the airport.

Together NPH and Yourgene will be offering 'Test To Release' for arriving international travellers, 'Fit to Fly' test certificates for departing passengers, and also general PCR coronavirus testing for the general public that live in the surrounding region. This testing service becomes available today at the airport in anticipation of a relaxation of lockdown rules in the near future. NPH is the sole provider of COVID-19 testing to LBA and Yourgene is the sole COVID-19 testing provider to NPH for the LBA contract.

Yourgene Genomic Services is a UK Government approved COVID-19 private testing provider for the Test to Release for International Travel scheme and for general coronavirus testing, as announced by the Company on 24 December 2020.

Lyn Rees, CEO of Yourgene commented: "We are thrilled to be partnering with NPH and Leeds Bradford Airport to offer our accurate, reliable and trusted COVID-19 testing service. While the timing of any lockdown relaxations and increases in passenger traffic are unclear at present, we are primed for when these restrictions are lifted at Leeds Bradford and other travel hubs around the country.

"We are proud to be part of the global effort to fight this pandemic by offering a high-class Genomics Services laboratories to our partners."

As Pahoo pointed out 'Seller in the background has finished'19-Feb-21 Taking a closer look
19-Feb-21 14:29:37 93.425 200,000 Sell* 95.00 100.00 186.85k O
19-Feb-21 14:29:52 91.75 100,000 Sell* 95.00 100.00 91.75k O
Both listed as sells, but at 14:29:37 the prices were 93.425, suggesting the 14:29:52 was a natural sell, then we had two larger buys before the bell at 16:30hrs, helping to push us up.
After the frenzy this weekend ..(ODX and others) I suspect that Monday morning will be a solid blue start. If so, nice one PAH00 : )

Today, I took an Innova test at a local pharmacy, (very helpful and professional) I received my notification via text 35 minutes later (test result negative) but there was no mention that the Innova test may only have a sensitivity of 78.3%. ! If this testing is going to work, we need 95%+ sensitivity, and it needs to be turned around in super quick time in a manner that stands scrutiny to the venues or work places that we are going to be returning to. This is where ABDX will shine.!

Fully agree Trusted, a very positive move back towards the Directors buys, a solid move up this afternoon.

A few tweets and a little momentum this afternoon, ABDX still has more upside than down. Some solid buys are appearing, nice and steady does it please : ) GLA

Company announcement, 12 February 2021 at 7:00 a.m. GMT / 9:00 a.m. EET
Inside information

TURKU - FINLAND - Faron Pharmaceuticals Oy (First North: FARON, AIM: FARN), the clinical stage biopharmaceutical company, announces today that the Bookbuild, announced on 11 February 2021, is now closed. The Placing comprises the issue of 3,521,127 Placing Shares at an Issue Price of €4.26 per Placing Share, which represents a 5% discount to the 30 day volume weighted average price on NASDAQ Helsinki First North Growth.

The Placing Shares to be issued amount to approximately 7.5 per cent of the issued shares and votes in the Company, immediately prior to the Placing. The Company raised aggregate gross proceeds of EUR 15 million in the Placing. Several new high-quality Continental European institutional investors participated in the Placing, expanding Faron's investor base, along with existing investors, as planned. The European Investment Council Fund, EIC, which had given a pre-commitment, was the largest of the new investors. Faron is the first publicly listed company that the EIC Fund has invested in.

Fully agree, CY confidentally answered plenty of questions and has very reassuring simple vision. LFT, World lead desire >because that what we do. Time to sit back, relax and be patient. : )

Thank you, MrB. A sea of blue trades to settle the nerves, it's very hard for MM's to hold back the tide at this rate. Look forward to the presentation. GLA

Echo that GLR, very positive start to the day. Massive spread as usual. I think it's a case of sitting back and letting the news flow though steadily : )

After all of the media coverage over the week end I really thought ABDX would come out with a clear and defined reply to the coverage. Coverage that is robust and reassuring. Not a '' I refer the right Honourable Gentleman to the answer I gave earlier...''
Shame its such a very weak response.

York, U.K. 8 February 2021: Abingdon Health plc (AIM: ABDX) ("the Company"), a leading international developer and manufacturer of high quality and effective rapid tests, notes the article published in the Daily Mail on 6 February 2021 and refers investors to the RNS announcements made on 29 December 2020, 26 January 2021 and 27 January 2021 which accurately reflect the Company's position and current performance.

A timely development, backed up with some solid buys over the last two days, a very blue day today. Softly softly does it.

01 February 2021
IDE Group Holdings plc, the mid-market network, cloud and IT managed services provider, provides a trading update for the year ended 31 December 2020. As indicated at the time of the Group's interim results in September, revenue and EBITDA in the second half of the year were slightly down on the first half, and IDE expects to report revenue of £23.6 million (FY19: £28.2 million) and Adjusted EBITDA* of approximately £0.5 million (FY19: £1.1 million) for the year ended 31 December 2020.

Is this a new Shares Magazine article today, as the RNS is dated 3rd November 2020 and after the original release the shares remained flat at 75p according the HL ODX News. It looks all positive but I don't see anything new ?

Full agree DaveBoy, having faith in the Directors and their own buys always helps me to relax over any minor short term fluctuations.
21st Jan 2021 5:41 pm RNS Director/PDMR Shareholding
19th Jan 2021 2:20 pm RNS Director/PDMR Shareholding
: ) GLA

HL back selling but at a big spread, 108 - 116 to buy. Back in but at the MM prices : ( GL

Hi V_W,
The trade is not shown as an uncrossing trade UT, so I am hoping its a buy this afternoon. However, the MM may well have put it down as a BUY when actually it was an early AM SELL. It's all very cloak and dagger at times. In my mind its a BUY : )
S.